TSRO Related FDA

Jun 4, 2013 09:08 AM TESARO (TSRO) Issues Encouraging Update for Niraparib Phase 1 in Ovarian Cancer

Jun 3, 2013 12:25 PM Deutsche Boosts PT on Tesaro (TSRO) to $80; Likes Netupitant, Potential for Niraparib